<VariationArchive VariationID="1751600" VariationName="NM_001021.6(RPS17):c.60del (p.Tyr21fs)" VariationType="Deletion" Accession="VCV001751600" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2022-11-29" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1811221" VariationID="1751600">
      <GeneList>
        <Gene Symbol="RPS17" FullName="ribosomal protein S17" GeneID="6218" HGNC_ID="HGNC:10397" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q25.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="82536750" stop="82540457" display_start="82536750" display_stop="82540457" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NT_187606.1" start="325856" stop="329563" display_start="325856" display_stop="329563" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="82821160" stop="82824864" display_start="82821160" display_stop="82824864" Strand="-" />
          </Location>
          <OMIM>180472</OMIM>
          <Haploinsufficiency last_evaluated="2015-12-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS17">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-12-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS17">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001021.6(RPS17):c.60del (p.Tyr21fs)</Name>
      <CanonicalSPDI>NC_000015.10:82540075:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q25.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="82540076" stop="82540076" display_start="82540076" display_stop="82540076" variantLength="1" positionVCF="82540075" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="82824484" stop="82824484" display_start="82824484" display_stop="82824484" variantLength="1" positionVCF="82824483" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>Y21fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.82540076del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.82540076del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.82824484del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.82824484del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009890.2" sequenceAccession="NG_009890" sequenceVersion="2" change="g.5469del">
            <Expression>NG_009890.2:g.5469del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001021.6" sequenceAccession="NM_001021" sequenceVersion="6" change="c.60del" MANESelect="true">
            <Expression>NM_001021.6:c.60del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001012.1" sequenceAccession="NP_001012" sequenceVersion="1" change="p.Tyr21fs">
            <Expression>NP_001012.1:p.Tyr21fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_111943.2" sequenceAccession="NR_111943" sequenceVersion="2" change="n.382del">
            <Expression>NR_111943.2:n.382del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_111944.3" sequenceAccession="NR_111944" sequenceVersion="3" change="n.89del">
            <Expression>NR_111944.3:n.89del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1143" sequenceAccession="LRG_1143">
            <Expression>LRG_1143:g.5469del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1143t1" sequenceAccession="LRG_1143t1">
            <Expression>LRG_1143t1:c.60del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1143p1" sequenceAccession="LRG_1143p1" change="p.Tyr21fs">
            <Expression>LRG_1143p1:p.Tyr21fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001021.6(RPS17):c.60del (p.Tyr21fs) AND Diamond-Blackfan anemia" Accession="RCV002360148" Version="3">
        <ClassifiedConditionList TraitSetID="1756">
          <ClassifiedCondition DB="MedGen" ID="C1260899">Diamond-Blackfan anemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-12-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-12-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-11-29" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1756" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1485" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Diamond-Blackfan anemia</ElementValue>
                <XRef ID="MONDO:0015253" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS105650" DB="OMIM" />
                <XRef ID="88854002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blackfan Diamond syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anemia congenital erythroid hypoplastic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aregenerative anemia chronic congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Erythrogenesis imperfecta</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Red cell aplasia, pure hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital hypoplastic anemia</ElementValue>
                <XRef ID="HP:0004810" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aase syndrome</ElementValue>
                <XRef ID="MONDO:0015253" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DBA</ElementValue>
                <XRef Type="MIM" ID="105650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BDS</ElementValue>
                <XRef Type="MIM" ID="105650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Diamond-Blackfan anemia (DBA) is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50%, and growth deficiency in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia or no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.</Attribute>
                <XRef ID="NBK7047" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6274" />
                <XRef ID="6274" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301769</ID>
                <ID Source="BookShelf">NBK7047</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3083626</ID>
              </Citation>
              <XRef ID="124" DB="Orphanet" />
              <XRef ID="C1260899" DB="MedGen" />
              <XRef ID="D029503" DB="MeSH" />
              <XRef ID="MONDO:0015253" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS105650" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004810" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005545" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5141680" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a870637|MedGen:C1260899" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002659983" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-12-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.60delC pathogenic mutation, located in coding exon 2 of the RPS17 gene, results from a deletion of one nucleotide at nucleotide position 60, causing a translational frameshift with a predicted alternate stop codon (p.Y21Tfs*30). Since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPS17" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001021.3:c.60delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1260899" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5141680" TraitType="Disease" MappingType="XRef" MappingValue="C1260899" MappingRef="MedGen">
        <MedGen CUI="C1260899" Name="Diamond-Blackfan anemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

